Nomura Holdings announces a significant share buyback program while tightening risk controls at its digital asset unit, Laser Digital. The move signals a dual focus on immediate capital returns and long-term, regulated growth in the crypto space, as the financial giant navigates a volatile market.
Arcellx shares have delivered stellar multi-year gains, prompting investors to question if the rally still has room to run. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow models pointing to significant upside while price-to-book ratios suggest a more cautious stance.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Energy Recovery (ERII) sees its price target raised to $23 by analysts, reflecting increased confidence in the adoption timeline for its CO2 refrigeration technology, despite stable core valuation metrics. The shift underscores a nuanced market narrative focused on execution rather than a fundamental change in long-term prospects.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
Compass Point Research suggests the prolonged cryptocurrency downturn may be nearing its end, with Bitcoin finding a potential bottom around $60,000-$68,000 unless broader market turmoil intervenes.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
Palantir Technologies' stock surged after hours as the data analytics firm reported record quarterly results, fueled by its AI platform. CEO Alex Karp hailed an 'iconic' performance while warning that the company's dominance creates societal and political tensions.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
As Regal Rexnord prepares to release its fourth-quarter results, investors are watching to see if the industrial automation leader can sustain its recent stock momentum and deliver on growth forecasts in a mixed earnings season for machinery peers.
Offshore drilling contractor Noble Corporation bolsters its forward workload with a series of new multi-year contracts totaling approximately $1.3 billion, headlined by a major harsh-environment rig award in Norway, signaling a strategic geographic expansion and renewed confidence in the offshore cycle.
As Kulicke & Soffa prepares to release its fourth-quarter results, investors are watching to see if the semiconductor equipment specialist can meet elevated expectations amid a sector-wide rebound.
Elon Musk announces the merger of SpaceX and xAI, outlining an ambitious plan to construct solar-powered data centers in space, which he claims will become the most cost-effective source of AI computing power within years.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
The global insurer faces heightened scrutiny after a recent revenue miss, with analysts projecting a sharp year-over-year sales increase as peers post mixed results.
OpenText's appointment of former IBM Americas President Ayman Antoun as its new CEO, effective April 2026, has been met with a sharp sell-off. While the move brings deep cloud and AI expertise, investors appear wary of the leadership transition and strategic pivot amid ongoing portfolio restructuring and debt concerns.
All eyes are on Corpay (NYSE: CPAY) as the business payments firm prepares to release its quarterly results after Wednesday's closing bell. Analysts project robust revenue growth, but a history of misses adds intrigue to the report.
As Mueller Water Products prepares to release its fourth-quarter results, investors are watching for signs of sustained growth in the critical water infrastructure sector. The company has a strong track record of exceeding revenue expectations.
